Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Antitrust, appointed, AstraZeneca, Astria, baseline, borrowing, brand, caution, ceased, charge, choose, clearance, concept, conversion, criteria, customary, designee, detailing, disagree, final, formulation, genitourinary, gynecologic, implicated, incremental, interpret, JJDC, Johnson, killer, lymphoblastic, Minjuvi, newly, NK, opportunity, opt, proof, publicly, qualify, ratio, reached, RECIST, resale, robust, ROU, serving, split, topline, Unconfirmed, undesirable, unregistered, vibecotmab, viewed, vudalimab, weigh
Removed:
agent, launch, listed, reviewing
Filing tables
Filing exhibits
Related press release
Associated XNCR transcripts
XNCR similar filings
Filing view
External links